Related references
Note: Only part of the references are listed.5-Fluorouracil nano-delivery systems as a cutting-edge for cancer therapy
Anai A. Valencia-Lazcano et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2023)
Colorectal cancer statistics, 2023
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2023)
Stimuli-Responsive Multifunctional Nanomedicine for Enhanced Glioblastoma Chemotherapy Augments Multistage Blood-to-Brain Trafficking and Tumor Targeting
Claudia Martins et al.
SMALL (2023)
Clinical implication of tissue carcinoembryonic antigen expression in association with serum carcinoembryonic antigen in colorectal cancer
Abdulmohsin Fawzi Aldilaijan et al.
SCIENTIFIC REPORTS (2023)
PLGA/PEG Nanoparticles Loaded with Cyclodextrin-Peganum harmala Alkaloid Complex and Ascorbic Acid with Promising Antimicrobial Activities
Sherif Ashraf Fahmy et al.
PHARMACEUTICS (2022)
Clinical Value of Consensus Molecular Subtypes in Colorectal Cancer: A Systematic Review and Meta-Analysis
Sanne ten Hoorn et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2022)
PLGA-Based Nanomedicine: History of Advancement and Development in Clinical Applications of Multiple Diseases
Hashem O. Alsaab et al.
PHARMACEUTICS (2022)
Recent advances in PLGA micro/nanoparticle delivery systems as novel therapeutic approach for drug-resistant tuberculosis
Liqun Shao et al.
FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY (2022)
Genetic and microenvironmental intra-tumor heterogeneity impacts colorectal cancer evolution and metastatic development
Daniel Sobral et al.
COMMUNICATIONS BIOLOGY (2022)
Emerging new therapeutic antibody derivatives for cancer treatment
Shijie Jin et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2022)
Three dimensional cultivation increases chemo- and radioresistance of colorectal cancer cell lines
Jana Koch et al.
PLOS ONE (2021)
5-Fluorouracil efficacy requires anti-tumor immunity triggered by cancer-cell-intrinsic STING
Jingru Tian et al.
EMBO JOURNAL (2021)
Mechanism of acquired 5FU resistance and strategy for overcoming 5FU resistance focusing on 5FU metabolism in colon cancer cell lines
Tomonari Suetsugu et al.
ONCOLOGY REPORTS (2021)
5-Fluorouracil (5-FU) resistance and the new strategy to enhance the sensitivity against cancer: Implication of DNA repair inhibition
Chinmayee Sethy et al.
BIOMEDICINE & PHARMACOTHERAPY (2021)
Tumour immune microenvironment biomarkers predicting cytotoxic chemotherapy efficacy in colorectal cancer
Kate Wilkinson et al.
JOURNAL OF CLINICAL PATHOLOGY (2021)
Consensus molecular subtypes of colorectal cancer in clinical practice: A translational approach
Guillermo Valenzuela et al.
WORLD JOURNAL OF CLINICAL ONCOLOGY (2021)
Tumor-Associated Macrophages (TAMs) in Colorectal Cancer (CRC): From Mechanism to Therapy and Prognosis
Hui Wang et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
p28-functionalized PLGA nanoparticles loaded with gefitinib reduce tumor burden and metastases formation on lung cancer
Ana Rita Garizo et al.
JOURNAL OF CONTROLLED RELEASE (2021)
Metastatic heterogeneity of the consensus molecular subtypes of colorectal cancer
Peter W. Eide et al.
NPJ GENOMIC MEDICINE (2021)
Cytotoxicity of targeted PLGA nanoparticles: a systematic review
Hock Ing Chiu et al.
RSC ADVANCES (2021)
Immunomodulatory nanomedicine for colorectal cancer treatment: a landscape to be explored?
Maria Jose Silveira et al.
BIOMATERIALS SCIENCE (2021)
The Importance of Poly(ethylene glycol) Alternatives for Overcoming PEG Immunogenicity in Drug Delivery and Bioconjugation
Thai Thanh Hoang Thi et al.
POLYMERS (2020)
Strategies to Obtain Encapsulation and Controlled Release of Small Hydrophilic Molecules
Qi Li et al.
FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY (2020)
5-Fluorouracil resistance mechanisms in colorectal cancer: From classical pathways to promising processes
Sabrina Blondy et al.
CANCER SCIENCE (2020)
Recent Advances in Designing 5-Fluorouracil Delivery Systems: A Stepping Stone in the Safe Treatment of Colorectal Cancer
Elaheh Entezar-Almahdi et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2020)
Molecular markers of response to different chemotherapeutic agents in RAS / BRAF mutated colon cancer cell lines
K. Doello et al.
ANNALS OF ONCOLOGY (2020)
Phenomenology of the Initial Burst Release of Drugs from PLGA Microparticles
Jin Yoo et al.
ACS BIOMATERIALS SCIENCE & ENGINEERING (2020)
In vivo Bio-Distribution and Toxicity Evaluation of Polymeric and Lipid-Based Nanoparticles: A Potential Approach for Chronic Diseases Treatment
Joao Fonseca-Gomes et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2020)
M2 macrophages confer resistance to 5-fluorouracil in colorectal cancer through the activation of CCL22/PI3K/AKT signaling
Chen Wei et al.
ONCOTARGETS AND THERAPY (2019)
CEA expression heterogeneity and plasticity confer resistance to the CEA-targeting bispecific immunotherapy antibody cibisatamab (CEA-TCB) in patient-derived colorectal cancer organoids
Reyes Gonzalez-Exposito et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
Melatonin-mediated downregulation of thymidylate synthase as a novel mechanism for overcoming 5-fluorouracil associated chemoresistance in colorectal cancer cells
Aki Sakatani et al.
CARCINOGENESIS (2019)
Carcinoembryonic antigen-targeted photodynamic therapy in colorectal cancer models
Fortune M. K. Elekonawo et al.
EJNMMI RESEARCH (2019)
Polymeric nano-encapsulation of 5-fluorouracil enhances anti-cancer activity and ameliorates side effects in solid Ehrlich Carcinoma-bearing mice
Yusuf A. Haggag et al.
BIOMEDICINE & PHARMACOTHERAPY (2018)
Recent advances of PLGA micro/nanoparticles for the delivery of biomacromolecular therapeutics
Dawei Ding et al.
MATERIALS SCIENCE AND ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS (2018)
The effect of surface poly(ethylene glycol) length on in vivo drug delivery behaviors of polymeric nanoparticles
Ji-Long Wang et al.
BIOMATERIALS (2018)
Folic acid-decorated and PEGylated PLGA nanoparticles for improving the antitumour activity of 5-fluorouracil
Mazen M. El-Hammadi et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2017)
Multi-omics of 34 colorectal cancer cell lines - a resource for biomedical studies
Kaja C. G. Berg et al.
MOLECULAR CANCER (2017)
Novel anticarcinoembryonic antigen antibody-drug conjugate has antitumor activity in the existence of soluble antigen
Daisuke Shinmi et al.
CANCER MEDICINE (2017)
Tumor-associated macrophages and response to 5-fluorouracil adjuvant therapy in stage III colorectal cancer
Alberto Malesci et al.
ONCOIMMUNOLOGY (2017)
The consensus molecular subtypes of colorectal cancer
Justin Guinney et al.
NATURE MEDICINE (2015)
Macrophages stimulate gastric and colorectal cancer invasion through EGFR Y1086, c-Src, Erk1/2 and Akt phosphorylation and smallGTPase activity
A. P. Cardoso et al.
ONCOGENE (2014)
Expression and structural characterization of anti-T-antigen single-chain antibodies (scFvs) and analysis of their binding to T-antigen by surface plasmon resonance and NMR spectroscopy
Noriyuki Yuasa et al.
JOURNAL OF BIOCHEMISTRY (2013)
Nanoparticles functionalised with recombinant single chain Fv antibody fragments (scFv) for the magnetic resonance imaging of cancer cells
Kim L. Vigor et al.
BIOMATERIALS (2010)
Kinetics of anti-carcinoembryonic antigen antibody internalization: effects of affinity, bivalency, and stability
Michael M. Schmidt et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2008)
Effect of antigen turnover rate and expression level on antibody penetration into tumor spheroids
Margaret E. Ackerman et al.
MOLECULAR CANCER THERAPEUTICS (2008)
Directed evolution of an anti-carcinoembryonic antigen scFv with a 4-day monovalent dissociation half-time at 37°C
CP Graff et al.
PROTEIN ENGINEERING DESIGN & SELECTION (2004)
Reversible dimer formation and stability of the anti-tumour single-chain Fv antibody MFE-23 by neutron scattering, analytical ultracentrifugation, and NMR and FT-IR spectroscopy
YC Lee et al.
JOURNAL OF MOLECULAR BIOLOGY (2002)